{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:34:50Z","timestamp":1791495290053,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cld.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:02:16Z","timestamp":1572742936000},"page":"61-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Liver Histology"],"prefix":"10.1016","volume":"24","author":[{"given":"Billel","family":"Gasmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2019.09.004_bib1","first-page":"192","article-title":"Histopathologic changes associated with fialuridine hepatotoxicity","volume":"10","author":"Kleiner","year":"1997","journal-title":"Mod Pathol"},{"issue":"17","key":"10.1016\/j.cld.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2019.09.004_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.09.004_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archinte.1965.03860140008003","article-title":"Drug-induced liver disease: a penalty for progress","volume":"115","author":"Popper","year":"1965","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2019.09.004_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41379-018-0013-y","article-title":"Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury","volume":"31","author":"Zen","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.cld.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bcp.12231","article-title":"Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy","volume":"77","author":"Iacovelli","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.cld.2019.09.004_bib7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s10620-018-5023-6","article-title":"Acute liver failure from tumor necrosis factor-alpha antagonists: report of four cases and literature review","volume":"63","author":"Kok","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2019.09.004_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/phar.1677","article-title":"Anakinra-induced acute liver failure in an adolescent patient with still's disease","volume":"36","author":"Taylor","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.cld.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF01316809","article-title":"Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis","volume":"38","author":"Scully","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.cld.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma","volume":"57","author":"Kleiner","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.cld.2019.09.004_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/PAS.0000000000000453","article-title":"Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases","volume":"39","author":"Johncilla","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.cld.2019.09.004_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases","volume":"11","author":"Ghabril","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2019.09.004_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9629(15)40536-1","article-title":"Nitrofurantoin-induced immune-mediated lung and liver disease","volume":"317","author":"Schattner","year":"1999","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.cld.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid-associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.09.004_bib17","series-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","author":"Zimmerman","year":"1999"},{"issue":"4","key":"10.1016\/j.cld.2019.09.004_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajcp\/74.4.442","article-title":"Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases","volume":"74","author":"Mullick","year":"1980","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.cld.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0016-5085(86)90092-2","article-title":"Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas","volume":"90","author":"Vanderstigel","year":"1986","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2019.09.004_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/PAS.0000000000000759","article-title":"Fibrin ring granulomas in checkpoint inhibitor-induced hepatitis","volume":"41","author":"Everett","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cld.2019.09.004_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/apt.15211","article-title":"Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors","volume":"49","author":"Stolz","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2019.09.004_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","article-title":"Clinical and histologic features of azithromycin-induced liver injury","volume":"13","author":"Martinez","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2015.283","article-title":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury","volume":"110","author":"Fontana","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2016.05.003","article-title":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","volume":"65","author":"Medina-Caliz","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7497","key":"10.1016\/j.cld.2019.09.004_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.cld.2019.09.004_bib26","doi-asserted-by":"crossref","first-page":"e0203084","DOI":"10.1371\/journal.pone.0203084","article-title":"Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment","volume":"13","author":"Mori","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"8320","key":"10.1016\/j.cld.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(83)91629-X","article-title":"Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: further evidence for a causal relation between salicylate and Reye's syndrome","volume":"1","author":"Starko","year":"1983","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2019.09.004_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0022-3565(25)22984-6","article-title":"Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice","volume":"255","author":"Fromenty","year":"1990","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.cld.2019.09.004_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s13181-010-0047-0","article-title":"Severe drug-induced liver injury associated with prolonged use of linezolid","volume":"6","author":"De Bus","year":"2010","journal-title":"J\u00a0Med Toxicol"},{"issue":"5","key":"10.1016\/j.cld.2019.09.004_bib31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16 children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.cld.2019.09.004_bib32","first-page":"553","article-title":"Histological features and severity of oxaliplatin-induced liver injury and clinical associations","volume":"15","author":"Nalbantoglu","year":"2014","journal-title":"J\u00a0Dig Dis"},{"issue":"9","key":"10.1016\/j.cld.2019.09.004_bib33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","article-title":"Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease","volume":"28","author":"Geller","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cld.2019.09.004_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/PAS.0000000000000881","article-title":"The almost-normal liver biopsy: presentation, clinical associations, and outcome","volume":"41","author":"Czeczok","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.cld.2019.09.004_bib35","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1053\/j.gastro.2012.07.113","article-title":"Development of an accurate index for predicting outcomes of patients with acute liver failure","volume":"143","author":"Rutherford","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2019.09.004_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2007.03330.x","article-title":"The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury","volume":"25","author":"Bjornsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"10.1016\/j.cld.2019.09.004_bib37","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.3748\/wjg.v23.i23.4303","article-title":"Substantial hepatic necrosis is prognostic in fulminant liver failure","volume":"23","author":"Ndekwe","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2019.09.004_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"Bonkovsky","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2019.09.004_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2019.09.004_bib40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2019.09.004_bib41","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326119300686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326119300686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:26Z","timestamp":1761069386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326119300686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1089326119300686"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2019.09.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Histology","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}